• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22042 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Andalusian Health Technology Assessment Area (AETSA) Bioartificial liver. Systematic Review.
2015     Andalusian Health Technology Assessment Area (AETSA) Second generation prognostic genomic tests in early breast cancer: EndoPredict® y Prosigna™.
2015     Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of ecolizumab for the treatment of hemolytic syndrome atypical uremic
2015     Andalusian Health Technology Assessment Area (AETSA) FDG-PET/CT and SPECT for cancer staging.
2015     Andalusian Health Technology Assessment Area (AETSA) Focal therapy in localized prostate cancer: irreversible electroporation, HIFU and holmium laser
2015     Andalusian Health Technology Assessment Area (AETSA) Utility of QF_PCR in prenatal diagnosis of fetal aneuploidies
2015     Andalusian Health Technology Assessment Area (AETSA) Magnetic growth rods in early onset scoliosis with diverse etiology
2007     Andalusian Health Technology Assessment Area (AETSA) [Guide for decision-making on the introduction of genetic tests in the National Health System (GEN guide) Version 1]
2013     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of ankylosing spondylitis: a comparison of efficacy and safety between different biological inhibitors of tumour necrosis factor-alpha]
2015     Andalusian Health Technology Assessment Area (AETSA) Stentoplasty effectiveness and safety for the treatment of osteoporotic vertebral fractures
2008     Andalusian Health Technology Assessment Area (AETSA) [HER2 in selecting candidates to treatment with Trastuzumab. Determining HER2 status in breast cancer women]
2013     Andalusian Health Technology Assessment Area (AETSA) [Monoclonal antibodies associated with chemotherapy as first line therapy in metastatic colorectal cancer: relative efficacy, safety and efficiency]
2015     Andalusian Health Technology Assessment Area (AETSA) Active immunotherapy for lung cancer. Systematic review.
2006     Andalusian Health Technology Assessment Area (AETSA) [Expulsion stage of delivery: comparison of upright versus lying down positions for childbirth, through maternal and foetal outcomes]
2008     Andalusian Health Technology Assessment Area (AETSA) [Analysis of APC mutations to perform prophylactic colectomy in subjects at risk for colorectal cancer]
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and cost-effectiveness of molecular techniques in the intraoperative assessment of the sentinel lymph node]
2020     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of the macrobiotic diet]
2013     Andalusian Health Technology Assessment Area (AETSA) [New treatments in organ-confined cancer vs. prostatectomy. Systematic review. Ablation with cryotherapy, HIFU and laser-therapy]
2007     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of prophylactic surgery, chemoprevention, and intensive surveillance in women carriers of BRCA 1/2 gene mutations]
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy, safety and efficiency of transcutaneous nerve stimulation for the treatment of chronic musculoskeletal pain]
2014     Andalusian Health Technology Assessment Area (AETSA) Digital tomosynthesis in breast cancer. Systematic Review
2013     Andalusian Health Technology Assessment Area (AETSA) [Active immunotherapy for breast cancer]
2014     Andalusian Health Technology Assessment Area (AETSA) Anti TNF alpha drugs for adults with moderate to severe non fistulizing active Chron's disease.
2008     Andalusian Health Technology Assessment Area (AETSA) [Perfusion MR Imaging in differentiating brain gliomas. Meta-analysis and economic assessment]
2014     Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2008     Andalusian Health Technology Assessment Area (AETSA) [Multi-slice computerised tomography coronary angiography in detecting coronary stenosis. Meta-analysis and economic report.]
2008     Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Laparoscopy in acute cholecystitis, choledocholithiasis and cholelithiasis. Development of criteria for appropriateness]
2014     Andalusian Health Technology Assessment Area (AETSA) Incompatible living donor kidney transplantation.
2009     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2008     Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Knee arthroscopy. Development of criteria for appropriateness]
2014     Andalusian Health Technology Assessment Area (AETSA) Ranizumab and bevacizumab for the treatment of diabetic macular oedema.
2002     Andalusian Health Technology Assessment Area (AETSA) Appropriate use of short-cycle sterilization (flash sterilization) in non-urgent ophthalmological surgery - non-systematic review
2008     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG in assessing lymphoma. Systematic review of results after chemo and immunotherapy]
2008     Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Indications of intra-operative ablation in patients with atrial fibrillation. Development of criteria for appropriateness]
2014     Andalusian Health Technology Assessment Area (AETSA) Lumbar total disc replacement effectiveness and safety in chronic low back pain.
2002     Andalusian Health Technology Assessment Area (AETSA) Report on the hearing-aid device AUDIGITAL ALFA 128
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment of cerebrovascular disease]
2014     Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of kyphoplasty and vertebroplasty in osteoporotic vertebral compression fracture.
2003     Andalusian Health Technology Assessment Area (AETSA) Chemotherapy treatments in advanced cancer patients. Assessment of clinical practice and cost-effectiveness
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment of cerebrovascular disease]
2014     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of interspinous devices
2003     Andalusian Health Technology Assessment Area (AETSA) Report on New-Ger (N-duopropenide), a new disinfectant. 2002 update - non-systematic review
2008     Andalusian Health Technology Assessment Area (AETSA) [Outcomes of transanal endoscopic surgery in patients with rectal tumours]
2014     Andalusian Health Technology Assessment Area (AETSA) Sacroiliac joint fusion. Open versus minimally invasive surgery.
2003     Andalusian Health Technology Assessment Area (AETSA) Cambiando la practica profesional (translation to Spanish of the report published by DSI, Changing Professional Practice) - methodology for guidelines implementation
2008     Andalusian Health Technology Assessment Area (AETSA) [Telemedicine for monitoring of chronic diseases: Diabetes mellitus]
2007     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for primary prophylaxis against human papillomavirus infection]
2008     Andalusian Health Technology Assessment Area (AETSA) [Teledermatology. Systematic review and economic assessment]
2007     Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of osteogenic protein-1 in lumbar spine fusion surgery
2008     Andalusian Health Technology Assessment Area (AETSA) [Effectivity of new insulin analogs. A systematic review of the literature and economic assessment]
2007     Andalusian Health Technology Assessment Area (AETSA) Robot-assisted surgery using da Vinci robot telemanipulation in prostatectomy
2009     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of new oral antidiabetics. A systematic review of the literature and economic assessment]
2006     Andalusian Health Technology Assessment Area (AETSA) Assessing the effectivity of botulinum toxin Type A in miofascial pain yndrome treatment
2009     Andalusian Health Technology Assessment Area (AETSA) [The state of research into inequalities in the incidence, death, prevention and healthcare in cancer in Spain. A bibliometric study and literature review.]
2009     Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness of ozone therapies]
2010     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of nitrous oxide 50% mixed with oxygen in the use as inhalation analgesic during labor]
2008     Andalusian Health Technology Assessment Area (AETSA) [Standards for health technologies appropriateness: Cardiac resynchronization therapy]
2008     Andalusian Health Technology Assessment Area (AETSA) [Economic assessment of mitral valve insufficiency treatment]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in caring type 2 diabetes mellitus patients. Literature review and economic assessment]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in caring for patients with cancer]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in palliative care. A comparison on consumption of resources]
2007     Andalusian Health Technology Assessment Area (AETSA) [Universal leukorreduction. A systematic review of the literature and an economic assessment]
1999     Andalusian Health Technology Assessment Area (AETSA) [Implantable defibrillators: criteria for clinical indications and decision making on coverage - non-systematic review]
2000     Andalusian Health Technology Assessment Area (AETSA) [Gender dysphoria: possible interventions and coverage in Andalusian Health System - systematic review, economic evaluation]
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of ventricular assist devices]
2000     Andalusian Health Technology Assessment Area (AETSA) Positron emission tomography: research synthesis on effectiveness in specific indications - systematic review
2013     Andalusian Health Technology Assessment Area (AETSA) [A review of indications for ventricular assist device therapy]
1999     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of transmyocardial laser revascularization - systematic review]
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test]
2000     Andalusian Health Technology Assessment Area (AETSA) Non-pharmacological interventions in Parkinson's disease - systematic review, primary research
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy, safety and efficiency of electrical spinal cord stimulation for the treatment of chronic musculoskeletal pain]
2000     Andalusian Health Technology Assessment Area (AETSA) Telemedicine application in Andalusia - systematic review
2020     Andalusian Health Technology Assessment Area (AETSA) Cognitive training effectiveness for mild to moderate dementia patients. A systematic review
2009     Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2020     Andalusian Health Technology Assessment Area (AETSA) Genetic risk prediction test for cardiovascular disease
2020     Andalusian Health Technology Assessment Area (AETSA) Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2012     Andalusian Health Technology Assessment Area (AETSA) [Safety and effectiveness of oncolytic viruses in advanced cancer. systematic review of the literature]
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of inverted shoulder prosthesis for arthropathy of the rotator cuff: systematic review of the literature and appropriateness criteria]
2012     Andalusian Health Technology Assessment Area (AETSA) [Extended neonatal screening for lysosomal diseases by mass spectrometry]
2011     Andalusian Health Technology Assessment Area (AETSA) [Paediatric triage systems in hospital emergency department: reliability and validity]
2012     Andalusian Health Technology Assessment Area (AETSA) [New oral anticoagulants for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation]
2007     Andalusian Health Technology Assessment Area (AETSA) [Outcomes of treatments for stuttering]
2007     Andalusian Health Technology Assessment Area (AETSA) Guide for decision-making on the introduction of new genetic tests in the National Health System (GEN Guide)
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for the acquisition of new technologies
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guidance for the introduction of new drugs
2007     Andalusian Health Technology Assessment Area (AETSA) The efficacy of acupuncture in the management of chronic pain and in palliative care.
2011     Andalusian Health Technology Assessment Area (AETSA) [Analysis of health and socioeconomic factors influencing the progressive increase in frequentation of hospital emergency services]
2007     Andalusian Health Technology Assessment Area (AETSA) [Update of the guide for the introduction of new drugs (GINF)]
2007     Andalusian Health Technology Assessment Area (AETSA) The therapeutic utility of growth factors in hepatic regeneration
2010     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for the prevention of herpes zoster and postherpetic neuralgia in adults]
2007     Andalusian Health Technology Assessment Area (AETSA) Use of recombinant human erythropoietin in orthopedic surgery
2010     Andalusian Health Technology Assessment Area (AETSA) [Genetic screening of colorrectal neoplasms through fecal DNA analysis]
2013     Andalusian Health Technology Assessment Area (AETSA) [Treatments for localized prostate cancer: Radical prostatectomy versus brachytherapy. Systematic review of the literature and case series]
2003     Andalusian Health Technology Assessment Area (AETSA) Safety, efficacy and efficiency of transmyocardial laser. Update of evidence-Systematic Review.
2007     Andalusian Health Technology Assessment Area (AETSA) Intraperitoneal chemotherapy in advanced epithelial ovarian cancer
2010     Andalusian Health Technology Assessment Area (AETSA) [Immunisation against angiotensin II. A therapeutic vaccine against arterial hypertension]
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficiency of peritoneal dialysis versus hemodialysis for the treatment of renal insufficiency]
2004     Andalusian Health Technology Assessment Area (AETSA) Essure system for selective tubal occlusion - review
2007     Andalusian Health Technology Assessment Area (AETSA) Clinical applications of proteomic techniques